CN108936606A - Osteoarticular retrograde affection full nutrition formula food - Google Patents
Osteoarticular retrograde affection full nutrition formula food Download PDFInfo
- Publication number
- CN108936606A CN108936606A CN201810612556.4A CN201810612556A CN108936606A CN 108936606 A CN108936606 A CN 108936606A CN 201810612556 A CN201810612556 A CN 201810612556A CN 108936606 A CN108936606 A CN 108936606A
- Authority
- CN
- China
- Prior art keywords
- parts
- lactobacillus
- food
- vitamin
- bifidobacterium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 59
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 39
- 230000035764 nutrition Effects 0.000 title claims abstract description 30
- 239000003814 drug Substances 0.000 claims abstract description 58
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 34
- 229940079593 drug Drugs 0.000 claims abstract description 30
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 26
- 239000011707 mineral Substances 0.000 claims abstract description 26
- 235000013406 prebiotics Nutrition 0.000 claims abstract description 23
- 239000000843 powder Substances 0.000 claims abstract description 22
- 239000000463 material Substances 0.000 claims abstract description 20
- 239000000284 extract Substances 0.000 claims abstract description 19
- 150000001413 amino acids Chemical class 0.000 claims abstract description 17
- 210000000988 bone and bone Anatomy 0.000 claims description 33
- 239000000203 mixture Substances 0.000 claims description 23
- 229940024606 amino acid Drugs 0.000 claims description 20
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 18
- 241000186660 Lactobacillus Species 0.000 claims description 17
- 229940039696 lactobacillus Drugs 0.000 claims description 17
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 15
- 239000011575 calcium Substances 0.000 claims description 15
- 229910052791 calcium Inorganic materials 0.000 claims description 15
- 241000894006 Bacteria Species 0.000 claims description 13
- 229940088594 vitamin Drugs 0.000 claims description 13
- 239000011782 vitamin Substances 0.000 claims description 13
- 240000004371 Panax ginseng Species 0.000 claims description 11
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 11
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 11
- 244000197580 Poria cocos Species 0.000 claims description 11
- 235000008599 Poria cocos Nutrition 0.000 claims description 11
- 235000008434 ginseng Nutrition 0.000 claims description 11
- 244000189799 Asimina triloba Species 0.000 claims description 10
- 235000006264 Asimina triloba Nutrition 0.000 claims description 10
- 241000186000 Bifidobacterium Species 0.000 claims description 10
- 235000009467 Carica papaya Nutrition 0.000 claims description 10
- 241001264174 Cordyceps militaris Species 0.000 claims description 10
- 241000208688 Eucommia Species 0.000 claims description 10
- 235000011034 Rubus glaucus Nutrition 0.000 claims description 10
- 235000009122 Rubus idaeus Nutrition 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 10
- 210000000582 semen Anatomy 0.000 claims description 10
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 9
- 241000270273 Ptyas dhumnades Species 0.000 claims description 9
- 240000007651 Rubus glaucus Species 0.000 claims description 9
- 244000007853 Sarothamnus scoparius Species 0.000 claims description 9
- -1 compound amino acid Chemical class 0.000 claims description 9
- 229910052742 iron Inorganic materials 0.000 claims description 9
- 244000144730 Amygdalus persica Species 0.000 claims description 8
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 8
- 240000000759 Lepidium meyenii Species 0.000 claims description 8
- 235000000421 Lepidium meyenii Nutrition 0.000 claims description 8
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims description 8
- 238000005516 engineering process Methods 0.000 claims description 8
- 229940088598 enzyme Drugs 0.000 claims description 8
- 235000012902 lepidium meyenii Nutrition 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- 108090000790 Enzymes Proteins 0.000 claims description 7
- 102000004190 Enzymes Human genes 0.000 claims description 7
- 235000013361 beverage Nutrition 0.000 claims description 7
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 6
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 6
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 6
- 241000168517 Haematococcus lacustris Species 0.000 claims description 6
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 6
- 229930182816 L-glutamine Natural products 0.000 claims description 6
- 241000186605 Lactobacillus paracasei Species 0.000 claims description 6
- 235000013325 dietary fiber Nutrition 0.000 claims description 6
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 6
- 239000004615 ingredient Substances 0.000 claims description 6
- 239000003921 oil Substances 0.000 claims description 6
- 235000019198 oils Nutrition 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 6
- 241000186018 Bifidobacterium adolescentis Species 0.000 claims description 5
- 241000186016 Bifidobacterium bifidum Species 0.000 claims description 5
- 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 claims description 5
- 244000068988 Glycine max Species 0.000 claims description 5
- 235000010469 Glycine max Nutrition 0.000 claims description 5
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 5
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 5
- 241000186673 Lactobacillus delbrueckii Species 0.000 claims description 5
- 241000186840 Lactobacillus fermentum Species 0.000 claims description 5
- 241000186606 Lactobacillus gasseri Species 0.000 claims description 5
- 240000002605 Lactobacillus helveticus Species 0.000 claims description 5
- 235000013967 Lactobacillus helveticus Nutrition 0.000 claims description 5
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 5
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 5
- 241000186604 Lactobacillus reuteri Species 0.000 claims description 5
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims description 5
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 5
- 241000194020 Streptococcus thermophilus Species 0.000 claims description 5
- 229930003316 Vitamin D Natural products 0.000 claims description 5
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 5
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 5
- 229940002008 bifidobacterium bifidum Drugs 0.000 claims description 5
- 229940004120 bifidobacterium infantis Drugs 0.000 claims description 5
- 235000007215 black sesame Nutrition 0.000 claims description 5
- 239000006071 cream Substances 0.000 claims description 5
- 241000411851 herbal medicine Species 0.000 claims description 5
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims description 5
- 229940054346 lactobacillus helveticus Drugs 0.000 claims description 5
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 5
- 229940001882 lactobacillus reuteri Drugs 0.000 claims description 5
- 239000011574 phosphorus Substances 0.000 claims description 5
- 229910052698 phosphorus Inorganic materials 0.000 claims description 5
- 235000019166 vitamin D Nutrition 0.000 claims description 5
- 239000011710 vitamin D Substances 0.000 claims description 5
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 5
- 229940046008 vitamin d Drugs 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 239000011701 zinc Substances 0.000 claims description 5
- 229910052725 zinc Inorganic materials 0.000 claims description 5
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 claims description 4
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 claims description 4
- 241001608472 Bifidobacterium longum Species 0.000 claims description 4
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 4
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 4
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 4
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 4
- 239000004472 Lysine Substances 0.000 claims description 4
- 108010038807 Oligopeptides Proteins 0.000 claims description 4
- 102000015636 Oligopeptides Human genes 0.000 claims description 4
- 235000019486 Sunflower oil Nutrition 0.000 claims description 4
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 4
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims description 4
- 229940009289 bifidobacterium lactis Drugs 0.000 claims description 4
- 229940009291 bifidobacterium longum Drugs 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 4
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims description 4
- 238000004090 dissolution Methods 0.000 claims description 4
- 235000013601 eggs Nutrition 0.000 claims description 4
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 4
- 229960004488 linolenic acid Drugs 0.000 claims description 4
- 239000011777 magnesium Substances 0.000 claims description 4
- 229930182817 methionine Natural products 0.000 claims description 4
- 229920001542 oligosaccharide Polymers 0.000 claims description 4
- 150000002482 oligosaccharides Chemical class 0.000 claims description 4
- 239000004006 olive oil Substances 0.000 claims description 4
- 235000008390 olive oil Nutrition 0.000 claims description 4
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 4
- 239000002600 sunflower oil Substances 0.000 claims description 4
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 3
- 241000251468 Actinopterygii Species 0.000 claims description 3
- 239000004382 Amylase Substances 0.000 claims description 3
- 102000013142 Amylases Human genes 0.000 claims description 3
- 108010065511 Amylases Proteins 0.000 claims description 3
- 239000004475 Arginine Substances 0.000 claims description 3
- 241000186012 Bifidobacterium breve Species 0.000 claims description 3
- 108010059892 Cellulase Proteins 0.000 claims description 3
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 3
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 claims description 3
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 3
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 3
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 3
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 3
- 244000199885 Lactobacillus bulgaricus Species 0.000 claims description 3
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 claims description 3
- 244000199866 Lactobacillus casei Species 0.000 claims description 3
- 235000013958 Lactobacillus casei Nutrition 0.000 claims description 3
- 241000186869 Lactobacillus salivarius Species 0.000 claims description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 3
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 claims description 3
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 3
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 3
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 claims description 3
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 claims description 3
- 235000019483 Peanut oil Nutrition 0.000 claims description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 3
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 3
- 108010073771 Soybean Proteins Proteins 0.000 claims description 3
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 claims description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 3
- 229930003268 Vitamin C Natural products 0.000 claims description 3
- 229930003427 Vitamin E Natural products 0.000 claims description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 3
- 235000019418 amylase Nutrition 0.000 claims description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 3
- 229960002685 biotin Drugs 0.000 claims description 3
- 235000020958 biotin Nutrition 0.000 claims description 3
- 239000011616 biotin Substances 0.000 claims description 3
- 235000015895 biscuits Nutrition 0.000 claims description 3
- 229940106157 cellulase Drugs 0.000 claims description 3
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 3
- 229960001231 choline Drugs 0.000 claims description 3
- 229910052804 chromium Inorganic materials 0.000 claims description 3
- 239000011651 chromium Substances 0.000 claims description 3
- 239000010949 copper Substances 0.000 claims description 3
- 229910052802 copper Inorganic materials 0.000 claims description 3
- 239000002285 corn oil Substances 0.000 claims description 3
- 235000005687 corn oil Nutrition 0.000 claims description 3
- 230000007071 enzymatic hydrolysis Effects 0.000 claims description 3
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 claims description 3
- 239000011737 fluorine Substances 0.000 claims description 3
- 229910052731 fluorine Inorganic materials 0.000 claims description 3
- 229960000304 folic acid Drugs 0.000 claims description 3
- 239000011724 folic acid Substances 0.000 claims description 3
- 235000019152 folic acid Nutrition 0.000 claims description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 3
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 3
- 229960000310 isoleucine Drugs 0.000 claims description 3
- 229940004208 lactobacillus bulgaricus Drugs 0.000 claims description 3
- 229940017800 lactobacillus casei Drugs 0.000 claims description 3
- 239000000944 linseed oil Substances 0.000 claims description 3
- 235000021388 linseed oil Nutrition 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 229910052749 magnesium Inorganic materials 0.000 claims description 3
- 210000001161 mammalian embryo Anatomy 0.000 claims description 3
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 235000012054 meals Nutrition 0.000 claims description 3
- 235000013372 meat Nutrition 0.000 claims description 3
- 229910052750 molybdenum Inorganic materials 0.000 claims description 3
- 239000011733 molybdenum Substances 0.000 claims description 3
- 229960003512 nicotinic acid Drugs 0.000 claims description 3
- 235000001968 nicotinic acid Nutrition 0.000 claims description 3
- 239000011664 nicotinic acid Substances 0.000 claims description 3
- 229960003104 ornithine Drugs 0.000 claims description 3
- 229940055726 pantothenic acid Drugs 0.000 claims description 3
- 239000011713 pantothenic acid Substances 0.000 claims description 3
- 235000019161 pantothenic acid Nutrition 0.000 claims description 3
- 239000000312 peanut oil Substances 0.000 claims description 3
- 239000011591 potassium Substances 0.000 claims description 3
- 229910052700 potassium Inorganic materials 0.000 claims description 3
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims description 3
- 229910052711 selenium Inorganic materials 0.000 claims description 3
- 239000011669 selenium Substances 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 229940001941 soy protein Drugs 0.000 claims description 3
- 239000003549 soybean oil Substances 0.000 claims description 3
- 235000012424 soybean oil Nutrition 0.000 claims description 3
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 claims description 3
- 239000000758 substrate Substances 0.000 claims description 3
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 3
- 235000019155 vitamin A Nutrition 0.000 claims description 3
- 239000011719 vitamin A Substances 0.000 claims description 3
- 239000011715 vitamin B12 Substances 0.000 claims description 3
- 239000011716 vitamin B2 Substances 0.000 claims description 3
- 239000011726 vitamin B6 Substances 0.000 claims description 3
- 235000019154 vitamin C Nutrition 0.000 claims description 3
- 239000011718 vitamin C Substances 0.000 claims description 3
- 235000019165 vitamin E Nutrition 0.000 claims description 3
- 239000011709 vitamin E Substances 0.000 claims description 3
- 229940046009 vitamin E Drugs 0.000 claims description 3
- 229940045997 vitamin a Drugs 0.000 claims description 3
- 235000019742 Vitamins premix Nutrition 0.000 claims description 2
- 235000013312 flour Nutrition 0.000 claims description 2
- 235000003599 food sweetener Nutrition 0.000 claims description 2
- 235000013336 milk Nutrition 0.000 claims description 2
- 239000008267 milk Substances 0.000 claims description 2
- 210000004080 milk Anatomy 0.000 claims description 2
- GSSMIHQEWAQUPM-AOLPDKKJSA-N ovalbumin peptide Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C1=CN=CN1 GSSMIHQEWAQUPM-AOLPDKKJSA-N 0.000 claims description 2
- 238000009928 pasteurization Methods 0.000 claims description 2
- 239000011772 phylloquinone Substances 0.000 claims description 2
- MBWXNTAXLNYFJB-LKUDQCMESA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCCC(C)CCCC(C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-LKUDQCMESA-N 0.000 claims description 2
- 210000003296 saliva Anatomy 0.000 claims description 2
- 239000003765 sweetening agent Substances 0.000 claims description 2
- 229960003080 taurine Drugs 0.000 claims description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 2
- 239000011691 vitamin B1 Substances 0.000 claims description 2
- 108010088751 Albumins Proteins 0.000 claims 1
- 102000009027 Albumins Human genes 0.000 claims 1
- 241000333181 Osmanthus Species 0.000 claims 1
- 235000019082 Osmanthus Nutrition 0.000 claims 1
- 108090000526 Papain Proteins 0.000 claims 1
- 239000004365 Protease Substances 0.000 claims 1
- 235000013351 cheese Nutrition 0.000 claims 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims 1
- 229940055729 papain Drugs 0.000 claims 1
- 235000019834 papain Nutrition 0.000 claims 1
- 239000006041 probiotic Substances 0.000 abstract description 32
- 235000018291 probiotics Nutrition 0.000 abstract description 32
- 210000003734 kidney Anatomy 0.000 abstract description 17
- 150000001720 carbohydrates Chemical class 0.000 abstract description 14
- 210000004185 liver Anatomy 0.000 abstract description 12
- 210000000952 spleen Anatomy 0.000 abstract description 11
- 230000036039 immunity Effects 0.000 abstract description 10
- 239000002994 raw material Substances 0.000 abstract description 7
- 238000011160 research Methods 0.000 abstract description 7
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 3
- 208000026435 phlegm Diseases 0.000 abstract description 3
- 230000035479 physiological effects, processes and functions Effects 0.000 abstract description 3
- 230000001914 calming effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 25
- 230000006870 function Effects 0.000 description 20
- 235000001014 amino acid Nutrition 0.000 description 18
- 238000010521 absorption reaction Methods 0.000 description 16
- 230000000968 intestinal effect Effects 0.000 description 16
- 108090000623 proteins and genes Proteins 0.000 description 14
- 235000014633 carbohydrates Nutrition 0.000 description 13
- 235000019197 fats Nutrition 0.000 description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
- 201000010099 disease Diseases 0.000 description 11
- 238000009472 formulation Methods 0.000 description 11
- 235000018102 proteins Nutrition 0.000 description 11
- 102000004169 proteins and genes Human genes 0.000 description 11
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 8
- 239000002253 acid Substances 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 7
- 230000035622 drinking Effects 0.000 description 7
- 230000012010 growth Effects 0.000 description 7
- 235000008216 herbs Nutrition 0.000 description 7
- 230000010354 integration Effects 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- 235000015097 nutrients Nutrition 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 230000002708 enhancing effect Effects 0.000 description 6
- 239000000194 fatty acid Substances 0.000 description 6
- 229930003231 vitamin Natural products 0.000 description 6
- 235000013343 vitamin Nutrition 0.000 description 6
- 150000003722 vitamin derivatives Chemical class 0.000 description 6
- 108010051696 Growth Hormone Proteins 0.000 description 5
- 102000018997 Growth Hormone Human genes 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 239000000122 growth hormone Substances 0.000 description 5
- 210000000936 intestine Anatomy 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 239000003440 toxic substance Substances 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 238000009395 breeding Methods 0.000 description 4
- 230000001488 breeding effect Effects 0.000 description 4
- 239000002131 composite material Substances 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 239000004310 lactic acid Substances 0.000 description 4
- 235000014655 lactic acid Nutrition 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 4
- 208000015122 neurodegenerative disease Diseases 0.000 description 4
- 210000000963 osteoblast Anatomy 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 208000010392 Bone Fractures Diseases 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 206010017076 Fracture Diseases 0.000 description 3
- 229920002527 Glycogen Polymers 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 208000001132 Osteoporosis Diseases 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 230000007850 degeneration Effects 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 239000003862 glucocorticoid Substances 0.000 description 3
- 229940096919 glycogen Drugs 0.000 description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 3
- 229910052737 gold Inorganic materials 0.000 description 3
- 239000010931 gold Substances 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 210000004347 intestinal mucosa Anatomy 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 230000000529 probiotic effect Effects 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- YVWMHFYOIJMUMN-CYZWUHAYSA-N (6e,8e)-5-oxooctadeca-6,8-dienoic acid Chemical compound CCCCCCCCC\C=C\C=C\C(=O)CCCC(O)=O YVWMHFYOIJMUMN-CYZWUHAYSA-N 0.000 description 2
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 2
- 241001478240 Coccus Species 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 229930186217 Glycolipid Natural products 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 2
- 102000013275 Somatomedins Human genes 0.000 description 2
- 206010041497 Spermatorrhoea Diseases 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 108010046377 Whey Proteins Proteins 0.000 description 2
- 102000007544 Whey Proteins Human genes 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 231100000481 chemical toxicant Toxicity 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000021245 dietary protein Nutrition 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000002158 endotoxin Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 235000021323 fish oil Nutrition 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 210000004051 gastric juice Anatomy 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 208000013403 hyperactivity Diseases 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000003094 microcapsule Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 210000004126 nerve fiber Anatomy 0.000 description 2
- 235000008935 nutritious Nutrition 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 230000000391 smoking effect Effects 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 235000021119 whey protein Nutrition 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- HOMSOWZTBJWNHP-UHFFFAOYSA-N 5-chlorothiadiazole Chemical compound ClC1=CN=NS1 HOMSOWZTBJWNHP-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 206010002261 Androgen deficiency Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 208000006386 Bone Resorption Diseases 0.000 description 1
- 208000020084 Bone disease Diseases 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 206010006956 Calcium deficiency Diseases 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 240000007154 Coffea arabica Species 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 208000020401 Depressive disease Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 208000027244 Dysbiosis Diseases 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 208000037487 Endotoxemia Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 240000008892 Helianthus tuberosus Species 0.000 description 1
- 235000003230 Helianthus tuberosus Nutrition 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 206010020575 Hyperammonaemia Diseases 0.000 description 1
- 201000002980 Hyperparathyroidism Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 235000002710 Ilex cornuta Nutrition 0.000 description 1
- 241001310146 Ilex cornuta Species 0.000 description 1
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 208000030136 Marchiafava-Bignami Disease Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 208000029725 Metabolic bone disease Diseases 0.000 description 1
- 206010054949 Metaplasia Diseases 0.000 description 1
- 206010029216 Nervousness Diseases 0.000 description 1
- 206010029400 Nicotinic acid deficiency Diseases 0.000 description 1
- 235000010326 Osmanthus heterophyllus Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 208000002141 Pellagra Diseases 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 206010062104 Renal mass Diseases 0.000 description 1
- 229930189077 Rifamycin Natural products 0.000 description 1
- 244000235659 Rubus idaeus Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000040738 Sesamum orientale Species 0.000 description 1
- 241001591005 Siga Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000005250 Spontaneous Fractures Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical class IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- 206010047626 Vitamin D Deficiency Diseases 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- FRYDSOYOHWGSMD-UHFFFAOYSA-N [C].O Chemical compound [C].O FRYDSOYOHWGSMD-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 230000003556 anti-epileptic effect Effects 0.000 description 1
- 230000003262 anti-osteoporosis Effects 0.000 description 1
- 230000003471 anti-radiation Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000004097 bone metabolism Effects 0.000 description 1
- 230000018678 bone mineralization Effects 0.000 description 1
- 230000024279 bone resorption Effects 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 241000902900 cellular organisms Species 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000000973 chemotherapeutic effect Effects 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 235000012716 cod liver oil Nutrition 0.000 description 1
- 239000003026 cod liver oil Substances 0.000 description 1
- 235000016213 coffee Nutrition 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000005202 decontamination Methods 0.000 description 1
- 230000003588 decontaminative effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000007140 dysbiosis Effects 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000013110 gastrectomy Methods 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 210000000569 greater omentum Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 235000004280 healthy diet Nutrition 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 208000027700 hepatic dysfunction Diseases 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 235000008085 high protein diet Nutrition 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- 210000002490 intestinal epithelial cell Anatomy 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 description 1
- 229960000511 lactulose Drugs 0.000 description 1
- PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 208000024714 major depressive disease Diseases 0.000 description 1
- 201000003995 melancholia Diseases 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 230000015689 metaplastic ossification Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 230000007659 motor function Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- 244000039328 opportunistic pathogen Species 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 210000002997 osteoclast Anatomy 0.000 description 1
- VDYCLYGKCGVBHN-UHFFFAOYSA-N pachymaic acid Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC(=C)C(C)C)C(O)=O)C(O)CC21C VDYCLYGKCGVBHN-UHFFFAOYSA-N 0.000 description 1
- SRDNLMOBFKJOSD-UHFFFAOYSA-N pachymic acid Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C(O)=O)C(O)CC21C SRDNLMOBFKJOSD-UHFFFAOYSA-N 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000035778 pathophysiological process Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 208000030683 polygenic disease Diseases 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 235000021085 polyunsaturated fats Nutrition 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000010410 reperfusion Effects 0.000 description 1
- 229960003292 rifamycin Drugs 0.000 description 1
- HJYYPODYNSCCOU-ODRIEIDWSA-N rifamycin SV Chemical compound OC1=C(C(O)=C2C)C3=C(O)C=C1NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)\C=C\O[C@@]1(C)OC2=C3C1=O HJYYPODYNSCCOU-ODRIEIDWSA-N 0.000 description 1
- NZCRJKRKKOLAOJ-XRCRFVBUSA-N rifaximin Chemical compound OC1=C(C(O)=C2C)C3=C4N=C5C=C(C)C=CN5C4=C1NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)\C=C\O[C@@]1(C)OC2=C3C1=O NZCRJKRKKOLAOJ-XRCRFVBUSA-N 0.000 description 1
- 229960003040 rifaximin Drugs 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 108010048734 sclerotin Proteins 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 235000020238 sunflower seed Nutrition 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 239000005495 thyroid hormone Substances 0.000 description 1
- 229940036555 thyroid hormone Drugs 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 210000004885 white matter Anatomy 0.000 description 1
- 235000020795 whole food diet Nutrition 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pediatric Medicine (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention provides the specific full nutritional formulas of osteoarticular retrograde affection edible for patients.The formula is according to the requirement of " special medicine purposes formula food general rule ", in conjunction with the constitutive character of osteoarticular retrograde affection patient, the research achievements such as advanced physiology, medicine, nutrition and the clinical application of comprehensive nowadays American Harvard University, the marrow of the Traditional Chinese Medicine according to " middle residence that disappears is mended ", " balanced tone " theoretical (the dirty people having the same aspiration and interest of liver,spleen,kidney three is main principle) develop.The product uses the Chinese medical extract essence of a variety of dual-purpose of drug and food, a variety of probiotics, small peptide for primary raw material, it is mixed using prebiotics, carbohydrate, amino acid, fatty powder, multivitamin and minerals as auxiliary material, it can be used as the nutritional need that single source of nutrition meets osteoarticular retrograde affection patient, there are also temperature compensation heart kidney, calming the liver invigorating the spleen, benefiting qi for tranquillization, clearing heat and eliminating phlegm and the full nutrition formula foods for improving immunity.
Description
Technical field
The invention belongs to integration of drinking and medicinal herbs class formula and food technology fields, specifically by the tradition of " Chinese medicine of integration of drinking and medicinal herbs "
Chinese medicine marrow theory and " multiple probiotics " combine, and add with small peptide, prebiotics, amino acid, carbohydrate, rouge
Fat, multi-vitamins, composite mineral matter are osteoarticular retrograde affection full nutrition formula food made of auxiliary material.
Background technique
Osteoarticular retrograde affection is one group of osteopathy caused by many reasons, and bone tissue has normal calcification, calcium salt and base
Matter is in normal rates, and the metabolic bone disease with the characteristics of the reduction of unit volume inner bone tissues amount becomes, in most joint degenerative diseases
In change, caused by the reduction of bone tissue increases mainly due to bone absorption, by skeleton pain, be easy to fracture characterized by, be now bone
Even brittleness increases thus the risk of fracture greatly increases and is also easy to happen bone under slight wound or atraumatic situation
Folding, osteoarticular retrograde affection is a kind of multifactor caused chronic disease, usually without special clinical table before fracture occurs
Existing, disease women is common in postmenopausal women and the elderly more than male, with the increase Bones and joints regression of China's elderly population
It is all the health problem to merit attention, Bones and joints degeneration that venereal disease, which becomes disease incidence to be in ascendant trend in China or even the whole world,
Lesion is a complicated pathophysiological process, and the factor of existing bone tissue of pathogenic factor itself also has the other factors outside bone,
The former includes bone amount reduction, Bone Defect Repari deficiency, bone structure disorder, the intensity decline of bone, and especially bone metabolism mechanism is different
Often etc.;The latter is mainly influenced by variation in terms of biomethanics, especially stress, chronic strain, wound, with living habit
It is also related with quality etc., such as smoking, excessive consumption of alcohol, mental labour, calcium pickup deficiency, vitamin D deficiency, menstrual disorder and different
Often, hyperparathyroidism, the use of glucocorticoid, gastrectomy etc. are all osteoarticular retrograde affection risk factors,
1, inherent cause it is preliminary research shows that osteoarticular retrograde affection may be polygenic disease, (such as the dimension life of these genes
Plain D acceptor gene) may participate in bone amount acquisition and bone conversion regulation, but have apparent racial difference, not can confirm that so far
A certain specific gene serve in the generation of this epilepsy it is key, 2, calcium intake calcium be mineral composition most basic in sclerotin,
There are enough calcium intakes in bone uptake phase such as diet, can promote bone amount and formed and enough minerals are provided, calcium intake is not
Can cause lower peak bone mass completely, 3, the enough physical exertions of life style it is related with the formation of peak bone mass, Lack of Movement or mistake
Degree movement is easy to happen osteoporosis, and smoking, excessive drinking, high protein and high salt diet, a large amount of coffees of drink, VitD intake are not
Foot or illumination is few etc. be osteoarticular retrograde affection risk factor, 4, the promotion anabolism of hormonal growth hormone (GH) makees
With being conducive to bone calcification, bon e formation, GH can stimulate in liver and in bone insulin-like growth factor (IGF) generation, osteoblast
On have the receptor of GH and IGF-1, IGF-1 promotes the hyperplasia and differentiation of osteoblast, and GH can also influence the deposition of minerals in bone,
Androgen (mainly testosterone and dioxygen use up ketone) is in addition to acting on osteoblast promoting bone growing, also point of inhibition osteoclast
Change, when hypoandrogenism, since bone resorption is greater than bon e formation, is easy to happen osteoporosis, cortex class encloses alcohol hormonosis (such as library
Glad syndrome or long-term, extensive application glucocorticoid) it can inhibit osteoblast, bon e formation is reduced, joint degenerative disease is induced
The generation of change, and be easy to happen pathologic fracture, 5, drug in addition to glucocorticoid, excessive thyroid hormone treatment, anti-epileptic
Medicine, heparin, chemotherapeutic and the treatment of long-term lithium etc. are the risk factor of articular degeneration, and " integration of drinking and medicinal herbs " is that China is original
To one of the contribution of mankind's most worthy among medicine;Chinese medicine always emphasizes " medication is not so good as dietotherapy ", and dietotherapy is chased after as modern
Ask recover one's original simplicity, the optimal selection of healthy diet;It allows people to dispel slight illness during enjoying cuisines, avoids and have an injection, eat
Medicine or even pain of surgery;
For food of special nutrients, there are corresponding regulation and development and application in developed countries such as the U.S., European Union;And China
Wholefood clear stipulaties in GB29922-2013 " special medicine purposes formula food general rule " national food safety standard:
2.1.1 full nutrition formula food: it can be used as the special medicine purposes formula that single source of nutrition meets target group's nutritional need
Food;2.1.2 specific full nutritional formulas: it can be used as single source of nutrition and meet target group in specified disease or medicine shape
The special medicine purposes formula food of nutritional need under condition.
Traditional Chinese medicine thinks: " spleen (i.e. digestive system) is the foundation of acquired constitution ", stomach health are health sheet, human body battalion
Feeding 99% is needed by intestinal absorption, and intestinal bowel disease is also source of ten thousand diseases;But with age, profitable strain is (prebiotic in enteron aisle
Bacterium) ratio gradually decreases;If Bifidobacterium Bifidum accounts for 98% in infant period, 5% is only accounted for after 10%, 65 years old is down to when to the middle age;People
Older, probiotics is fewer, and function of intestinal canal is also gradually reduced therewith, more and more studies have shown that normal floras human consumption,
It is immune and disease-resistant etc. to have many irreplaceable roles;The change and a variety of diseases, especially enteron aisle of intestinal flora composition
The occurrence and development of disease are closely related, and find from existing clinical research: probiotics can play adjusting intestinal flora, control enteron aisle
Inflammatory effect is that one kind safely and effectively intervenes adjusting method;
The relationship of Dysbiosis and osteoarticular retrograde affection: experiment and clinical proof calcium deficiency and Tiny ecosystem have close pass
System, the variation of intestinal flora influence the absorption of calcium, especially lactic acid bacteria, mainly include lactobacillus, streptococcus, Bifidobacterium, intestines
Coccus etc. can produce lactic acid and acetic acid after fermenting in the intestine, can improve the utilization rates such as calcium, iron, phosphorus, promote iron and vitamin D
It absorbs.And intestinal microecology is unbalance, necessarily will affect the absorption of calcium, and the shortage of calcium will lead to articular degeneration;
Though direct probiotic oral has certain effect, since probiotics can not be colonized in enteron aisle, and stop, occupy-place are very
It is few, it is easy to run off, withdraws that rear harmful bacteria is easy to recur, and associated patient needs to take for a long time, and treatment cycle is long, often use rear recurrence rate
It is very high;For the treatment cycle for shortening associated patient, recurrence rate after being discontinued is reduced, this team is by existing to probiotics over nearly 3 years
The key technology research of field planting mechanism in enteron aisle, makes great efforts to seek to improve " Chinese medicine of integration of drinking and medicinal herbs " that probiotics is colonized in enteron aisle
Compound, it is contemplated that several key elements that probiotics is colonized in enteron aisle: the presence of prebiotics can play field planting effect, intestinal pH
The reduction of environment and the enteron aisle adhesive capacity etc. for improving probiotic cell, are based on above-mentioned element, this seminar is from tens of kinds of " medicine foods
The suitable food materials of screening in homologous Chinese medicine ", add prebiotics, and after L-Glutamine etc., there have to external source probio to be very strong fixed
Plant effect, the prescription selection for probiotics in enteral microecological formulation provide experimental basis;
Currently on the market favorably to food-borne small peptide be primary raw material, add the mushroom, dried orange peel, fructus lycii, mountain of dual-purpose of drug and food
Extract, multi-vitamins and the minerals of medicine, Poria cocos, rhizoma polygonati etc. form compound prescription, and there are also be main former using probiotics
The product of material combines the constitutive character of osteoarticular retrograde affection patient but without discovery, and the marrow according to Traditional Chinese Medicine is managed
By, vary with each individual, gold compatibility using the Chinese medical extract essence of a variety of dual-purpose of drug and food, a variety of probiotics, small peptide as primary raw material,
Using prebiotics, carbohydrate, amino acid, multivitamin, several mineral materials as full nutrition formula food, spy made of auxiliary material
Determine full nutrition formula food or similar products.
Goal of the invention
It is initiative by a variety of raising Bones and joints degenerative diseases the purpose of the present invention is on inheriting Chinese medicine marrow theory treatment method
Become patient the probiotics of immunity and the extract of " Chinese medicine of integration of drinking and medicinal herbs " compound combine, add with small peptide,
Amino acid, carbohydrate, multivitamin, several mineral materials are auxiliary material, can not only supplement osteoarticular retrograde affection trouble
Person institute essential nutrients improves body nutrition condition, moreover it is possible to adjust body function using the function factor in dual-purpose of drug and food Chinese herbal medicine
Can, probiotics can play adjusting intestinal flora, and toxic side effect is small, safe and effective, and the acceptable suitable Bones and joints of people move back
The specific full nutritional formulas of row venereal disease change edible for patients.
Summary of the invention
This R&D team suffers from according to the requirement of " special medicine purposes formula food general rule " in conjunction with osteoarticular retrograde affection
The constitutive character of person, the research such as advanced physiology, medicine, nutrition and clinical application of comprehensive nowadays American Harvard University at
Fruit, the marrow of the Traditional Chinese Medicine according to " middle residence that disappears is mended ", " balanced tone " is theoretical (the dirty people having the same aspiration and interest of liver,spleen,kidney three is main principle), adopts
It is primary raw material with the Chinese medical extract essence of 3 kinds or more dual-purpose of drug and food, a variety of probiotics, small peptide, with prebiotics, carbon hydrate
Object, amino acid, multivitamin and minerals auxiliary material can be used as single source of nutrition and meet osteoarticular retrograde affection trouble
The nutritional need of person invigorates the spleen and benefits qi, reunion of fractured tendons and bones, keeps fit and healthy, warming kidney and enhancing yang and anti-there are also warm The strong bone of kidney tonifying, nourshing kidney moistening lung
(what is be combined into answers full nutrition formula food, specific full nutritional formulas or the non-whole nutritional formula food of osteoporosis function
Close formula);
1, the main component of inventive formulation
Chinese medical extract is dirty from the liver,spleen,kidney three in theory of traditional Chinese medical science according to the constitutive character of osteoarticular retrograde affection patient
The people having the same aspiration and interest is main principle, adjusts body function using the function factor in dual-purpose of drug and food Chinese herbal medicine and builds up resistance, and is chosen following
A few major class drugs carry out compatibility;Wherein: Cordyceps militaris enters lung kidney two warp, can tonifying lung yin and kidney-replenishing, cure mainly kidney deficiency, impotence
Spermatorrhea, soreness of waist and knee joint, eak after being ill, chronic cough is weak, phthisical cough phlegm blood, spontaneous sweating etc..Maca contains maca ene and macamide,
Maca ene and macamide have the function of good adjusting human hormone secretion, have and alleviate climacteric syndrome, improve Asia
Health status effect.Raspberry has liver-kidney tonifying, and astringent sperm contracting urine cures mainly impotence and premature ejaculation, emission and spermatorrhea effect.Line leaf broom top
There is the effect of calm central nervous system, is suitble to having allergy, headache, sleep disorder, insomnia, nervous, slight melancholia
Effect.Rhizoma polygonati is sweet in flavor mild-natured, can boosting qi and nourishing yin, invigorating the spleen, moistening lung, kidney-nourishing.Cortex cinnamomi extremely hot in nature, it is acrid flavour, sweet, control the Yang-function insufficiency of kidneyzang, limb
Cold weak pulse, yang depletion collapse, abdominal pain diarrhoea, cold hernia renal mass, waist and knee crymodynia.Ginseng can reinforce vital energy, veins takes off admittedly, reinforce the spleen to benefit the lung,
Shengjin nourishing, tranquilize the mind and promote the intelligence.Fructus lycii is sweet in flavor, mild-natured, nourishing the liver, nourshing kidney, moistening lung, cure mainly caused by liver and kidney deficiency, have a dizzy spell, visually not
Clearly, soreness and weakness of waist and knees.Eucommia Bark male flower enhances adrenal cortex function, promotes sleep, eliminates the effect of constipation.Poria cocos medicinal peace,
Contained pachymic acid has the function of strengthen immunity, antitumor and calm, hypoglycemic etc..Radix Glycyrrhizae is sweet in flavor mild-natured, can tonifying spleen benefit
Gas, clearing heat and detoxicating, expelling phlegm and arresting coughing, relieving spasm to stop pain, coordinating the drug actions of a prescription;
Chinese medical extract of the present invention refer to Cordyceps militaris, maca, raspberry, zaocys dhumnade, Radix et Rhizoma Gynurae divaricatae, line leaf broom top,
3 kinds therein of rhizoma polygonati, cortex cinnamomi, pawpaw, ginseng, semen coicis, rhizoma zingiberis, Radix Glycyrrhizae, fructus lycii, eucommia Bark male flower, Poria cocos, peach kernel or more or
All, simultaneously microencapsulation is extracted using biological enzymolysis or prehydrolysis SBE, it is mixed after spray-dried and freeze-drying extract
Close object;
2, a variety of probiotics
So that probiotics is largely reached enteron aisle by the strong acid environment of stomach, to promote the proliferation of probiotics, adjusts the micro- life of enteral
State balance, promotes the absorption to microelement, enhances taste motor function, accelerates the absorption of drug effect, improve the micro- of mucous membrane surface
The balance of biota or enzyme, or stimulation body specificity or nonspecific immunity mechanism, improve body colonization resistance or immunity;
Xing etc. pre-processes law during ischemia/reperfusion rat with Bifidobacterium and Bacillus acidi lactici, can be substantially reduced intestinal endotoxemia
Horizontal and preventing liver injury generation;Selective enteron aisle decontamination dye is also the important measures of adjustment intestinal microecology, there is research
It does not absorb that rifamycin antibiotic former times is bright (rifaximin) using enteron aisle, passes through the life for inhibiting urease-producing in enteron aisle and producing ammonium bacteria
It is long, to build up resistance;
A variety of probiotics of the present invention all use the probiotics after microencapsulation, in addition to streptococcus thermophilus, wherein bifid
Bacillus: refer to bifidobacterium adolescentis, bifidobacterium lactis, bifidobacterium bifidum, bifidobacterium breve, bifidobacterium infantis, long bifid
Bacillus is one of, several or whole mixes;Lactobacillus refers to: lactobacillus acidophilus powder, Lactobacillus casei, bulgarian milk bar
Bacterium, Lactobacillus delbrueckii, newborn subspecies lactobacillus gasseri, lactobacillus fermenti, Lactobacillus helveticus, Lactobacillus salivarius, Lactobacillus rhamnosus,
Lactobacillus reuteri, lactobacillus plantarum, lactobacillus paracasei, Yue Shi lactobacillus are one of, several or whole mixes;
3, small peptide
As oligopeptide refers to the small molecule egg of the separation and Extraction from animal or vegetable protein using bio-enzyme engineering technology
White matter, average molecular weight hereinafter, soluble easily in water, to acid, thermostabilization, can be not required to direct by digestion in 1000Dalton
It absorbs, bioavailability is high, is absorbing and using upper better than free amino acid and complete protein, can be applied to protein
In supplement, particularly with the low crowd of abilities of digestive and absorption, small peptide is splendid nitrogen source, in addition to trophic function, small peptide
Also there are a series of physiological active functions: improving the digestion and absorption function of small intestine, enhance immunity of organisms, it is anti-oxidant, it is auxiliary
Adjusting blood glucose is helped, auxiliary adjustment of blood fat, aided blood pressure-lowering is anti-radiation, promotes mineral absorption, enhances dual-purpose of drug and food Chinese herbal medicine
The function and effect of middle function factor;
Small peptide of the present invention refers to ocean fish oligopeptide, sea bone peptide, Soyprotein peptide, whey protein peptide, albumen egg
White peptide is one of, several or whole mixes;
4, prebiotics
To promote probiotics intestinal colonisation, enteron aisle convergence, reduce intestinal pH environment, also do not utilized by most of enteron aisle spoilage organisms,
But beneficial bacteria in human body can be promoted --- lactobacillus, Bifidobacterium growth and breeding, so as to inhibit spoilage organisms to grow,
Help to improve and maintain enteron aisle normal function;Long-term consumption can delay aging, defaecation, improve immunity, mitigation liver is born
Load, the absorptivity for improving nutrient, can especially improve absorption of the body to metal ions such as calcium, iron, zinc;Optionally
Outside the growth and breeding for promoting beneficial bacterium (bifid, lactic acid), also metabolizable is the organic acids such as acid product such as lactic acid, makes colon p
H value reduces, and inhibits the growth of intestinal harmful bacillus;So that small enteral Water-Electrolyte is trapped in enteric cavity, generates height and ooze effect, stimulation
Enterocinesia causes laxative, to promote intestinal endotoxin and the discharge of other toxicants, lactulose can also directly inactivate enteron aisle
Middle endotoxin reduces gut pH, has been widely applied to the treatment of enhancing child resistant;
Prebiotics of the present invention are 2 classes
A. there are very strong field planting effect prebiotics: semen coicis, ginseng, Radix Glycyrrhizae, the extract of jerusalem artichoke, wood to external source probio
Sugar, yeast are therein several or all mix;
B. common prebiotics: oligoisomaltose, oligofructose, soyabean oligosaccharides, xylo-oligosaccharide are one such, several or complete
Portion's mixing;
Originally refer to that oligoisomaltose, stachyose, oligofructose, soyabean oligosaccharides, xylo-oligosaccharide are one such, several or complete
Portion's mixing;
5, carbohydrate
Carbohydrate is made of three kinds of carbon, hydrogen and oxygen elements, it is that three kinds of main nutrition of thermal energy are provided for human body
Most cheap nutrient in element, when intake is sufficient, in vivo can rapid oxidation energy is provided in time, avoid valuable protein
For providing energy, carbohydrate be also the glycoprotein of cell membrane, nerve fiber glycolipid and convey hereditary information de-
The important composition ingredient of oxygen ribonucleic acid (DNA), and the glycogen contained in carbohydrate, when it lays in abundance in liver
When, the toxin that liver cell generates certain toxic chemical substances and various pathogenic microorganisms has stronger detoxification ability;
Carbohydrate of the present invention refers to glucose, fructose, galactolipin, lactose, L-arabinose, maltose, water-soluble
Property dietary fiber, starch, glycogen, haematococcus pluvialis be one such, several or all mixing;
6. amino acid
It is divided into essential amino acid and nonessential amino acid, is the basic unit for constituting protein, assigns the specific molecule of protein
Structural form makes it have biochemical activity;Absorbing suitable methionine facilitates the metabolism of various sulfur-containing compounds in human body simultaneously
And the methyl contained by it methylates to Toxic or drug and plays the role of removing toxic substances;Leucine can repair muscle, control
Blood glucose processed, and energy is provided to bodily tissue, it is necessary to amino acid phenylalanine can inhibit cancer growth, and can reduce drug
Toxic side effect, lysine can be improved the absorption and utilization of food protein, reaches balanced nutritious, enhancing development;Smart ammonia
Acid helps the ammonia in blood being changed into urea and excrete out;For hyperammonemia, hepatic dysfunction etc. is powerful;
Histidine reduces gastric acidity, mitigates the pain of gastrointestinal procedures, mitigates gestational period vomiting and scorching hot sense, inhibits by plant mind
It festers through alimentary canal caused by anxiety, it is also powerful to anaphylactia, such as asthma;Tryptophan can prevent pellagra,
Depression improves sleep and adjusts mood;
Amino acid of the present invention refer to L-Glutamine, methionine, isoleucine, tyrosine, phenylalanine, lysine,
Arginine, histidine, tryptophan, citrulling, ornithine, taurine are one such, several or whole mixes;
7. fatty powder
Fat is commonly called as grease, is made of carbon, hydrogen and oxygen element;It is both important composition part and the heat of tissue
One of main matter of amount;Fat in food digests in stomach, most of after absorption to be changed into fat once again again;It is main
Be distributed in around subcutis, omentum majus, mesenterium and kidney etc.;The trigalloyl that fat is made of glycerol and fatty acid
Glyceride, wherein the molecule of glycerol is fairly simple, and the type of fatty acid and length is not identical;Fatty acid divides three categories: full
With fatty acid, monounsaturated fatty acids, polyunsaturated fatty acid;The source of fat can divide following two kinds: animality source: animal
The fat stored in vivo: such as lard, butter, sheep oil, fish oil, marrow, fat meat, cod-liver oil;Fat in animal cream: such as cream
Deng;Vegetalitas source: vegetablefats source is mainly extracted out of fruit in plant, such as sesame, sunflower seed, tea life, core
Peach, pine nut, soya bean etc.;It is compound by a variety of fatty acid, adjust saturated fatty acid, monounsaturated fatty acids, polyunsaturated fat
The content ratio of acid is that the ratio of 1:1:1, ω -6 and ω -3 are 10:1 ~ 2:1, preferably 5:1 ~ 2:1, preferred 2:1;It has been especially added with 2-
8 parts of omega-fatty acid, source include addition embedding material after the combination of one or both of fish oil, algae oil, are obtained through homogeneous
Then emulsion is obtained fatty powder using screening by being dried in spray drying device by emulsion;
Fat of the present invention refer to MCT powder, alpha-linolenic acid, linoleic acid, corn oil, soybean oil, peanut oil, sunflower oil,
Olive oil, linseed oil, embryo oil are one such, several or whole mixes;
8. vitamin and mineral
Vitamin and mineral is nutrient needed by human, and the vitamin added in the present invention is that vitamin and mineral is people
Nutrient necessary to body;
The vitamin added in the present invention is vitamin A, vitamin D, vitamin E, vitamin K, vitamin K1, vitamin C, dimension
Raw element B1, vitamin B2, vitamin B6, vitamin B12, niacin, folic acid, pantothenic acid, choline, biotin be one such, Ji Zhonghuo
All mixing;
The minerals added in the present invention are that calcium, phosphorus, potassium, sodium, magnesium, chlorine, iron, zinc, selenium, copper, manganese, iodine, fluorine, chromium, molybdenum are therein
A kind of, several or whole mixing, minerals of the present invention are added to the organic or inorganic compound of the minerals;
9. the present invention is with microcapsules, biological enzymolysis, prehydrolysis SBE, spray drying and freeze-drying integrated innovation, the industry of composition
The key technology that metaplasia produces;Microencapsulation protection technique efficiently solves oral process high temperature and strong acid gastric juice to prebiotic
The inactivation of bacterium;Using three layers of buried microcapsules technology of protein, then with extracted through biological enzymolysis or prehydrolysis SBE technology and micro- glue
Encapsulated treated Chinese medical extract is uniformly mixed, and is coexisted with solution " multiple probiotics " and " Chinese medicine of integration of drinking and medicinal herbs " component
Problem has certain resistant to high temperatures and strong acid characteristic, is conducive to probiotics and is stopped by oral pass through in gastric juice arrival enteron aisle
The effect of staying field planting, making product greatly improves compared with the similar product of market;
10. various ingredients to be uniformly mixed to solid beverage, the granule that powdery is made using above-mentioned integrated innovation technique, and dispense
It directly drinks or is taken in through nasal feeding after (45 DEG C) of about 150ml warm water dissolutions at 10g/ packet;Appropriate attached material can also be added
Capsule, tablet is made or be added brown sugar and black sesame powder be made biscuit etc. quickly, instant food convenient for it is outgoing carry it is edible, if doing
It is then saved at beverage spray-dried, adds auxiliary material etc. less, be distributed into 10-65ml/ bottle, early, middle and late 0.5 hour after meal daily
Each 1 bottle of drink, all operations are in the clean dried environment for meeting " special medicine purposes formula food Good Manufacture Practice " requirement
Interior progress;
The characteristic of this formula full nutrition formula food and its following aspects is mainly manifested in the effect of body:
1. the present invention is the requirement according to " special medicine purposes formula food general rule ", in conjunction with osteoarticular retrograde affection patient's
Constitutive character, the research achievements developments such as advanced physiology, medicine, nutrition and the clinical application of comprehensive nowadays American Harvard University
, it varies with each individual, gold compatibility;
2. the marrow of the Traditional Chinese Medicine of present invention foundation " middle residence that disappears is mended ", " balanced tone " is theoretical, (liver,spleen,kidney three is dirty to be adjusted to together
Main principle), use the Chinese medical extract essence of a variety of dual-purpose of drug and food, a variety of probiotics, small peptide for primary raw material, with prebiotics,
Carbohydrate, amino acid, multivitamin and minerals are auxiliary material, and the organic assembling of various ingredients carries out various functions
Fusion, and pass through the synergistic effect between effective component, humidification effect;
3. there is effective absorbency, using inventive formulation, food of the various components using suitable ratio collocation preparation, warp
It is in isotonic state after a certain amount of water dissolution, small intestine can be reached quickly through stomach, absorbed quickly, completely, bone pass can be supplemented rapidly
Nutrition needed for saving degenerative disease;
4. not only being mentioned using the extract of various dual-purpose of drug and food Chinese herbal medicines containing multiple functions active constituent in inventive formulation
The high concentration of function factor, reduces the intake of various impurity, helps to mitigate liver kidney burden, have enhancing resistance of human body
Effect invigorates the spleen and benefits qi, reunion of fractured tendons and bones, keeps fit and healthy, warming kidney and enhancing yang and anti-osteoporosis function there are also The strong bone of kidney tonifying, nourshing kidney moistening lung
Effect;
5. probiotics contained in inventive formulation, a variety of probiotics can safeguard enteron aisle normal bacteria colony balance, inhibit disease
The growth of opportunistic pathogen prevents gastrointestinal disorders etc., and vitamin, amino acid are synthesized in enteron aisle and improves absorption of the body to calcium ion,
Enhance human immunologic function, prevent the side effect of antibiotic, improves host to the tolerance of radioactive ray, lactobacillus dramatically increases intestines
Mucosal immunity globulin A (SIgA) content has adjustment effect to body intestinal mucosa local immunity, adjusts stomach, intestines Tiny ecosystem, energy
The utilization rate of calcium, phosphorus, iron is improved, promotes the absorption of iron and vitamin D, the absorption of cholesterol can also be reduced;
6. inventive formulation food is using the food-borne bioactive short peptide in a variety of sources as nitrogen source, because small peptide is not required to digestion i.e.
It is absorbable, it is more advantageous to the utilization of body, twitch, hyperactivity patient's negative nitrogen balance, and food-borne small peptide can be effectively improved
The structure and function that intestinal epithelial cell can be improved improves the absorbability of intestinal mucosa;
7. prescription uses what this team was studied by being colonized the key technology of mechanism over nearly 3 years in enteron aisle to probiotics
Achievement improves " Chinese medicine of integration of drinking and medicinal herbs " compound that probiotics is colonized in enteron aisle, and the presence for combining prebiotics, which can be played, to be determined
The elements such as the enteron aisle adhesive capacity of plant effect, the reduction of intestinal pH environment and raising probiotic cell, therefore the food formula
Composition greatly strengthens the field planting effect to external source probio;
8. prebiotics contained in inventive formulation inhibit the growth of spoilage organisms by the growth and breeding of promotion enteral probiotics,
One of protective barrier is formed in intestinal mucosal surface simultaneously, damage of the enteron aisle spoilage organisms to intestinal mucosa can be resisted, reducing enteral has
The absorption of evil substance, can also promote intestines peristalsis, accelerate the discharge of enteral residuals, can prevent constipation, and pass through
Promote the growth and breeding of beneficial bacteria of intestinal tract that immunity of organisms also can be enhanced, small peptide, carbohydrate and active polysaccharide etc. are biological
Active material has synergistic effect;
9, carbohydrate contained in inventive formulation is that three kinds of main nutrients of thermal energy are provided for human body, in vivo
Can rapid oxidation energy is provided in time, avoid being used to valuable protein to provide energy, carbohydrate is also cell membrane
The important composition ingredient of glycoprotein, the glycolipid of nerve fiber and the DNA (DNA) to convey hereditary information, and carbon
The glycogen contained in hydrate, when it lays in abundance in liver, liver cell is to certain toxic chemical substances and various causes
The toxin that sick microorganism generates has stronger detoxification ability;
10, amino acid contained in inventive formulation is the basic unit for constituting protein, assigns the specific molecule knot of protein
It is configured state, makes it have biochemical activity, facilitates the metabolism of various sulfur-containing compounds in human body and the methyl contained by it is to having
Poisonous substance or drug are methylated and play the role of removing toxic substances, and muscle can be repaired, and control blood glucose, and provide energy to bodily tissue
Amount, also can be improved the absorption and utilization of food protein, reaches balanced nutritious, enhancing development;
11, inventive formulation food contains multivitamin and minerals, can supplement rapidly micro needed for twitch, hyperactivity patient
Nutrient, small peptide is by further increasing the absorptivity of mineral matter element with after the chelating of calcium, iron, zinc etc.;
12, fatty in inventive formulation, maize germ oil, sunflower oil lack ω -3-PUFA rich in ω -6-PUFA;Olive
Oil, tea-seed oil are rich in monounsaturated fatty acids (MUFA), can increase rouge while supplementing protein, micronutrient
The intake of fat avoids the adverse effect of the high protein diets such as meat, egg.
Specific embodiment
Below by following embodiment, the invention will be further described, it will be helpful to understand the present invention;
Realizing the object of the invention osteoarticular retrograde affection full nutrition formula food is to combine osteoarticular retrograde affection patient
Constitutive character, the marrow according to Traditional Chinese Medicine is theoretical, varies with each individual, gold compatibility is mentioned with the Chinese medicine of 3 kinds or more dual-purpose of drug and food
Taking object essence, a variety of probiotics, small peptide is primary raw material, with prebiotics, carbohydrate, amino acid, multivitamin, a variety of
Minerals are food made of auxiliary material;Bifidobacterium is selected from bifidobacterium adolescentis, bifidobacterium lactis, bifidobacterium bifidum, short pair
Discrimination bacillus, bifidobacterium infantis, bifidobacterium longum one or more;Lactobacillus be selected from lactobacillus acidophilus powder, Lactobacillus casei,
Lactobacillus bulgaricus, Lactobacillus delbrueckii, newborn subspecies lactobacillus gasseri, lactobacillus fermenti, Lactobacillus helveticus, Lactobacillus salivarius,
Lactobacillus rhamnosus, lactobacillus reuteri, lactobacillus plantarum, lactobacillus paracasei, Yue Shi lactobacillus one or more;Small peptide
One or more selected from ocean fish oligopeptide, sea bone peptide, Soyprotein peptide, whey protein peptide, ovalbumin peptide;It is prebiotic
Member is selected from oligoisomaltose, stachyose, oligofructose, the one or more of soyabean oligosaccharides, xylo-oligosaccharide;Amino acid is selected from
Methionine, isoleucine, tyrosine, phenylalanine, lysine, arginine, histidine, tryptophan, citrulling, ornithine, ox
The one or more of sulfonic acid;Fat selected from MCT powder, alpha-linolenic acid, linoleic acid, corn oil, soybean oil, peanut oil, sunflower oil,
The one or more of olive oil, linseed oil, embryo oil;Vitamin premix is selected from vitamin A, vitamin D, vitamin E, dimension
Raw element K1, vitamin C, vitamin B1, vitamin B2, vitamin B6, vitamin B12, niacin, folic acid, pantothenic acid, choline, biotin
One or more of Deng;Mineral substance premix is selected from calcium, phosphorus, potassium, sodium, magnesium, iron, zinc, selenium, copper, manganese, iodine, fluorine, chromium, molybdenum etc.
One or more of;
Embodiment one
It selects following formula and ratio to be made and is mixed for osteoarticular retrograde affection full nutrition formula food: by following raw materials according
And its dosage is formulated: the extract of dual-purpose of drug and food: 15 parts of Cordyceps militaris, 15 parts of maca, 15 parts of raspberry, 15 parts of zaocys dhumnade,
15 parts of Radix et Rhizoma Gynurae divaricatae, 15 parts of rhizoma polygonati, 15 parts of cortex cinnamomi, 15 parts of pawpaw, 10 parts of ginseng, 10 parts of semen coicis, is done at 15 parts of line leaf broom top
10 parts of ginger, 10 parts of Radix Glycyrrhizae, 5 parts of fructus lycii, 5 parts of eucommia Bark male flower, 5 parts of Poria cocos, 5 parts of peach kernel;75 parts of Bifidobacterium, lactobacillus 75
It is part, 40 parts of streptococcus thermophilus, 100 parts of L-Glutamine, 100 parts of small peptide, 100 parts of prebiotics, 100 parts of compound amino acid, water-soluble
Property 100 parts of dietary fiber, 150 parts of fatty powder, 5 parts of haematococcus pluvialis, 5 parts of multi-vitamins;50 parts of composite mineral matter;
First by Cordyceps militaris, maca, raspberry, zaocys dhumnade, Radix et Rhizoma Gynurae divaricatae, line leaf broom top, rhizoma polygonati, cortex cinnamomi, pawpaw, people when production
Cellulase, pectase, pawpaw egg is added after impregnating in ginseng, semen coicis, rhizoma zingiberis, Radix Glycyrrhizae, fructus lycii, eucommia Bark male flower, Poria cocos, peach kernel
White enzyme and amylase, 1 mg/g substrate of enzyme dosage, pH value is 4.0, in 50 DEG C of enzymatic hydrolysis 3h, solid-liquid ratio 1:15, with life
It is spray-dried and be prepared into flour after object zymolysis technique extracts Chinese medicine essence, then add biological enzymolysis extraction small peptide,
Prebiotics, amino acid, water-soluble dietary fiber, MCT powder, alpha-linolenic acid, linoleic acid, haematococcus pluvialis, multi-vitamins and mine
It is carried out after material mixing pasteurization 1 hour, Bifidobacterium (bifidobacterium adolescentis, newborn bifid after then adding microencapsulation
Bacillus, bifidobacterium bifidum, bifidobacterium breve, bifidobacterium infantis, bifidobacterium longum), lactobacillus it is (lactobacillus acidophilus powder, dry
Lactobacillus paracasei, lactobacillus bulgaricus, Lactobacillus delbrueckii, newborn subspecies lactobacillus gasseri, lactobacillus fermenti, Lactobacillus helveticus, saliva
Liquid lactobacillus, Lactobacillus rhamnosus, lactobacillus reuteri, lactobacillus plantarum, lactobacillus paracasei, Yue Shi lactobacillus), thermophilic chain
Coccus and uniformly mixed solid beverage, the granule that powdery is made of the various ingredients mixed, and it is distributed into 10g/ packet, with about
After (45 degree) of 150ml warm water dissolutions, directly drinks or taken in through nasal feeding;Appropriate attached material can also be added, capsule, tablet is made
Or be added sweetener and black sesame powder be made biscuit etc. quickly, instant food carry edible convenient for outgoing, saved if being made into beverage
It goes spray-dried, adds black sesame powder etc. less, be distributed into 50ml/ bottle, respectively drink 1 bottle within daily early, middle and late 0.5 hour after meal, institute
There is operation to carry out in clean dried environment;
Embodiment two
Above-mentioned osteoarticular retrograde affection full nutrition formula food is also an option that following formula and ratio are made and is mixed for
Osteoarticular retrograde affection full nutrition formula food: the extract of dual-purpose of drug and food: 18 parts of Cordyceps militaris, 18 parts of raspberry, zaocys dhumnade
18 parts, 18 parts of Radix et Rhizoma Gynurae divaricatae, 18 parts of rhizoma polygonati, 18 parts of cortex cinnamomi, 10 parts of ginseng, 10 parts of semen coicis, 10 parts of rhizoma zingiberis, 10 parts of Radix Glycyrrhizae, Chinese holly
10 parts of matrimony vine, 10 parts of eucommia Bark male flower, 10 parts of Poria cocos, 10 parts of peach kernel;75 parts of Bifidobacterium, 75 parts of lactobacillus, streptococcus thermophilus 40
Part, 100 parts of L-Glutamine, 100 parts of small peptide, 100 parts of prebiotics, 100 parts of compound amino acid, 100 parts of water-soluble dietary fiber,
150 parts of fatty powder, 5 parts of haematococcus pluvialis, 5 parts of multi-vitamins;50 parts of composite mineral matter;
Embodiment three
Above-mentioned osteoarticular retrograde affection full nutrition formula food is also an option that following formula and ratio are made and is mixed for
Osteoarticular retrograde affection full nutrition formula food: the extract of dual-purpose of drug and food: 15 parts of Cordyceps militaris, 15 parts of raspberry, zaocys dhumnade
15 parts, 15 parts of Radix et Rhizoma Gynurae divaricatae, 15 parts of line leaf broom top, 15 parts of rhizoma polygonati, 15 parts of cortex cinnamomi, 15 parts of pawpaw, 10 parts of ginseng, semen coicis 10
Part, 10 parts of rhizoma zingiberis, 10 parts of Radix Glycyrrhizae, 5 parts of fructus lycii, 5 parts of eucommia Bark male flower, 5 parts of Poria cocos;It is 65 parts of Bifidobacterium, 65 parts of lactobacillus, thermophilic
60 parts of hot streptococcus, 100 parts of L-Glutamine, 100 parts of small peptide, 100 parts of prebiotics, 100 parts of compound amino acid, aqueous soluble dietary
100 parts of fiber, 150 parts of fatty powder, 5 parts of multi-vitamins;50 parts of composite mineral matter.
Claims (5)
1. osteoarticular retrograde affection full nutrition formula food, it is characterised in that its material composition content include by weight under
Column component: the extract of dual-purpose of drug and food: 10-20 parts of Cordyceps militaris, 10-20 parts of maca, 10-20 parts of raspberry, zaocys dhumnade 10-20
Part, 10-20 parts of Radix et Rhizoma Gynurae divaricatae, 10-20 parts of line leaf broom top, 10-20 parts of rhizoma polygonati, 10-20 parts of cortex cinnamomi, 8-15 parts of pawpaw, ginseng
8-15 parts, 8-15 parts of semen coicis, 8-15 parts of rhizoma zingiberis, 5-10 parts of Radix Glycyrrhizae, 5-10 parts of fructus lycii, 5-10 parts of eucommia Bark male flower, Poria cocos 5-
10 parts, 5-10 parts of peach kernel;50-100 parts of Bifidobacterium (bifidobacterium adolescentis, bifidobacterium lactis, not tally bifid after microencapsulation
Bacillus, bifidobacterium breve, bifidobacterium infantis, bifidobacterium longum), 50-100 parts of lactobacillus (lactobacillus acidophilus powder, cheese cream bar
Bacterium, lactobacillus bulgaricus, Lactobacillus delbrueckii, newborn subspecies lactobacillus gasseri, lactobacillus fermenti, Lactobacillus helveticus, saliva cream bar
Bacterium, Lactobacillus rhamnosus, lactobacillus reuteri, lactobacillus plantarum, lactobacillus paracasei, Yue Shi lactobacillus), streptococcus thermophilus
20-60 parts, 50-150 parts of L-Glutamine, small peptide 50-150 parts of (ocean fish oligopeptide, sea bone peptide, Soyprotein peptide, creams
Albumin peptide, ovalbumin peptide), 50-150 parts of prebiotics (oligoisomaltose, stachyose, oligofructose, soyabean oligosaccharides,
Xylo-oligosaccharide), 50-150 parts of compound amino acid (methionine, isoleucine, tyrosine, phenylalanine, lysine, arginine,
Histidine, tryptophan, citrulling, ornithine, taurine), 50-150 parts of water-soluble dietary fiber, 100-200 parts of fatty powder
(MCT powder, alpha-linolenic acid, linoleic acid, corn oil, soybean oil, peanut oil, sunflower oil, olive oil, linseed oil, embryo oil),
3-8 parts of haematococcus pluvialis, vitamin premix (vitamin A, vitamin D, vitamin E, vitamin K1, vitamin C, vitamin
B1, vitamin B2, vitamin B6, vitamin B12, niacin, folic acid, pantothenic acid, choline, biotin) 5 parts;Mineral substance premix (calcium,
Phosphorus, potassium, sodium, magnesium, iron, zinc, selenium, copper, manganese, iodine, fluorine, chromium, molybdenum) 50 parts;
First by Cordyceps militaris, maca, raspberry, zaocys dhumnade, Radix et Rhizoma Gynurae divaricatae, line leaf broom top, rhizoma polygonati, cortex cinnamomi, pawpaw, people when production
Cellulase, pectase, pawpaw egg is added after impregnating in ginseng, semen coicis, rhizoma zingiberis, Radix Glycyrrhizae, fructus lycii, eucommia Bark male flower, Poria cocos, peach kernel
White enzyme and amylase, enzyme dosage 0.2-2 mg/g substrate, pH value are 3.0-5.0, in 40-60 DEG C of 1~5h of enzymatic hydrolysis, material
Liquor ratio 1:10~20, it is spray-dried and be prepared into flour after extracting Chinese medicine essence with biological enzymolysis technology, then add
Pasteurization is carried out after small peptide, prebiotics, amino acid, water-soluble dietary fiber, fatty powder, multi-vitamins and minerals mixing
1 hour, Bifidobacterium (bifidobacterium adolescentis, bifidobacterium lactis, bifidobacterium bifidum, short pair after then adding microencapsulation
Discrimination bacillus, bifidobacterium infantis, bifidobacterium longum), lactobacillus (lactobacillus acidophilus powder, Lactobacillus casei, bulgarian milk bar
Bacterium, Lactobacillus delbrueckii, newborn subspecies lactobacillus gasseri, lactobacillus fermenti, Lactobacillus helveticus, Lactobacillus salivarius, Lactobacillus rhamnosus,
Lactobacillus reuteri, lactobacillus plantarum, lactobacillus paracasei, Yue Shi lactobacillus), streptococcus thermophilus and the various ingredients that mix it is mixed
Uniformly solid beverage, the granule of powdery is made in conjunction, and is distributed into 10g/ packet, after (45 DEG C) of about 150ml warm water dissolutions, directly
It connects and drinks or taken in through nasal feeding;Appropriate attached material can also be added capsule, tablet is made or sweetener and black sesame powder is added and be made
Biscuit etc. quickly, instant food carry edible convenient for outgoing, saved if being made into beverage spray-dried, add black sesame powder less
Deng being distributed into 10-65ml/ bottles, daily early, middle and late 0.5 hour after meal each 1 bottle of drink, all operations are in clean dried environment
It carries out.
It further include by weight following 2. osteoarticular retrograde affection full nutrition formula food according to claim 1
Component: the extract of dual-purpose of drug and food: Cordyceps militaris, maca, raspberry, zaocys dhumnade, Radix et Rhizoma Gynurae divaricatae, line leaf broom top, rhizoma polygonati, meat
Osmanthus, pawpaw, ginseng, semen coicis, rhizoma zingiberis, Radix Glycyrrhizae, fructus lycii, eucommia Bark male flower, Poria cocos, peach kernel all mix.
3. above-mentioned osteoarticular retrograde affection full nutrition formula food further includes the dual-purpose of drug and food Chinese herbal medicine extract and new
Raw-food material are as follows: Cordyceps militaris, maca, raspberry, zaocys dhumnade, Radix et Rhizoma Gynurae divaricatae, line leaf broom top, rhizoma polygonati, cortex cinnamomi, pawpaw, ginseng,
Semen coicis, rhizoma zingiberis, Radix Glycyrrhizae, fructus lycii, eucommia Bark male flower, Poria cocos, peach kernel, haematococcus pluvialis all mix.
4. osteoarticular retrograde affection full nutrition formula food according to claim 1, is characterized in that according to the formula
Mixing can be prepared into powdery, graininess, capsule shape, tablet shape, beverage based food.
5. osteoarticular retrograde affection full nutrition formula food according to claim 1, is characterized in that Chinese medicine zymolysis technique,
Conspiracy relation between one group of enzyme, enzyme dosage 0.2-2 are formed using cellulase, pectase, papain and amylase
Mg/g substrate, pH value is 3.0-5.0, in 40-60 DEG C of 1~5h of enzymatic hydrolysis, solid-liquid ratio 1:10~20.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810612556.4A CN108936606A (en) | 2018-06-14 | 2018-06-14 | Osteoarticular retrograde affection full nutrition formula food |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810612556.4A CN108936606A (en) | 2018-06-14 | 2018-06-14 | Osteoarticular retrograde affection full nutrition formula food |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108936606A true CN108936606A (en) | 2018-12-07 |
Family
ID=64488664
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810612556.4A Pending CN108936606A (en) | 2018-06-14 | 2018-06-14 | Osteoarticular retrograde affection full nutrition formula food |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108936606A (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104839664A (en) * | 2015-04-10 | 2015-08-19 | 劲膳美生物科技股份有限公司 | Medical formula food for osteoporosis |
-
2018
- 2018-06-14 CN CN201810612556.4A patent/CN108936606A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104839664A (en) * | 2015-04-10 | 2015-08-19 | 劲膳美生物科技股份有限公司 | Medical formula food for osteoporosis |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104187611A (en) | Total nutrient formula food for gastrointestinal malabsorption | |
CN107568736A (en) | Dealcoholic sobering-up medical science formula food | |
CN104839664A (en) | Medical formula food for osteoporosis | |
CN104187632A (en) | Total-nutrient formulated food eaten by patients with osteoporosis | |
CN105533705A (en) | Medical formula food for recuperating women during second trimester | |
CN104839661A (en) | High uric acid formula food | |
CN104256642A (en) | Fully nutrient formula food for lowering high blood pressure, high blood sugar and high blood lipid and strengthening yang | |
CN104855994A (en) | Non-full nutritional formula food for patients with nephropathy | |
CN104187645A (en) | Anti-aging full-nutrition formula food | |
CN108968037A (en) | Senile dementia full nutrition formula food | |
CN108936628A (en) | A kind of specific full nutritional formulas and preparation method thereof that patients with cerebral apoplexy is edible | |
CN104839656A (en) | Liver disease medicine formula food | |
CN104839684A (en) | Medical formula food for people with helicobacter pylori related gastritis | |
CN105029393A (en) | Medical formula food for children | |
CN104187651A (en) | High-uric-acid prevention total-nutrition formula food | |
CN105380263A (en) | Full-nutrition formula food for treating pregnant woman constipation | |
CN105326038A (en) | Pregnant-woman pregnancy-vomiting total-nutrient formula food | |
CN104839678A (en) | Medical formula food for people with nephrosis | |
CN104839655A (en) | High blood lipids, blood sugar and blood pressure lowering and yang tonifying medical formula food | |
CN107319550A (en) | Brain trauma full nutrition formula food | |
CN107334156A (en) | Lactagogue full nutrition formula food | |
CN104996992A (en) | Medical formula food for muscle attenuation syndromes | |
CN104187643A (en) | All-nutrition formula food for yang-deficiency constitution | |
CN104187637A (en) | Full-nutritional formula food for tonifying Yang | |
CN104146254A (en) | Full-nutrition formulated food for hypertension |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181207 |
|
RJ01 | Rejection of invention patent application after publication |